| Immunologic correlates of the abscopal effect in a patient with melanoma MA Postow, MK Callahan, CA Barker, Y Yamada, J Yuan, S Kitano, Z Mu, ... New England Journal of Medicine 366 (10), 925-931, 2012 | 2148 | 2012 |
| Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment AM Lesokhin, TM Hohl, S Kitano, C Cortez, D Hirschhorn-Cymerman, ... Cancer research 72 (4), 876-886, 2012 | 406 | 2012 |
| CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy H Kagamu, S Kitano, O Yamaguchi, K Yoshimura, K Horimoto, ... Cancer immunology research 8 (3), 334-344, 2020 | 192 | 2020 |
| Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC K Kaira, T Higuchi, I Naruse, Y Arisaka, A Tokue, B Altan, S Suda, A Mogi, ... European journal of nuclear medicine and molecular imaging 45, 56-66, 2018 | 187 | 2018 |
| Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype D Hirschhorn-Cymerman, S Budhu, S Kitano, C Liu, F Zhao, H Zhong, ... Journal of Experimental Medicine 209 (11), 2113-2126, 2012 | 180 | 2012 |
| Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy Y Nakamura, S Kitano, A Takahashi, A Tsutsumida, K Namikawa, ... Oncotarget 7 (47), 77404, 2016 | 157 | 2016 |
| Granzyme B is a novel interleukin-18 converting enzyme Y Omoto, K Yamanaka, K Tokime, S Kitano, M Kakeda, T Akeda, ... Journal of dermatological science 59 (2), 129-135, 2010 | 151 | 2010 |
| Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel S Kageyama, S Kitano, M Hirayama, Y Nagata, H Imai, T Shiraishi, ... Cancer science 99 (3), 601-607, 2008 | 147 | 2008 |
| Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab S Kimbara, Y Fujiwara, S Iwama, K Ohashi, A Kuchiba, H Arima, ... Cancer science 109 (11), 3583-3590, 2018 | 146 | 2018 |
| Comparison of tumor‐infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients R Ogiya, N Niikura, N Kumaki, G Bianchini, S Kitano, T Iwamoto, ... Cancer science 107 (12), 1730-1735, 2016 | 138 | 2016 |
| Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes S Kitano, MA Postow, CGK Ziegler, D Kuk, KS Panageas, C Cortez, ... Cancer immunology research 2 (8), 812-821, 2014 | 138 | 2014 |
| Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients S Kitano, T Tsuji, C Liu, D Hirschhorn-Cymerman, C Kyi, Z Mu, JP Allison, ... Cancer immunology research 1 (4), 235-244, 2013 | 135 | 2013 |
| HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan S Kitano, S Kageyama, Y Nagata, Y Miyahara, A Hiasa, H Naota, ... Clinical cancer research 12 (24), 7397-7405, 2006 | 135 | 2006 |
| Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor MK Callahan, G Masters, CA Pratilas, C Ariyan, J Katz, S Kitano, ... Cancer immunology research 2 (1), 70-79, 2014 | 106 | 2014 |
| Clinical development of immune checkpoint inhibitors A Ito, S Kondo, K Tada, S Kitano BioMed research international 2015, 2015 | 98 | 2015 |
| Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma K Hatogai, S Kitano, S Fujii, T Kojima, H Daiko, S Nomura, T Yoshino, ... Oncotarget 7 (30), 47252, 2016 | 91 | 2016 |
| Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE Y Miyahara, H Naota, L Wang, A Hiasa, M Goto, M Watanabe, S Kitano, ... Clinical cancer research 11 (15), 5581-5589, 2005 | 82 | 2005 |
| Tumor‐associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma A Kawachi, H Yoshida, S Kitano, Y Ino, T Kato, N Hiraoka Cancer science 109 (3), 863-870, 2018 | 76 | 2018 |
| Pretreatment immune status correlates with progression-free survival in chemotherapy-treated metastatic colorectal cancer patients K Tada, S Kitano, H Shoji, T Nishimura, Y Shimada, K Nagashima, K Aoki, ... Cancer immunology research 4 (7), 592-599, 2016 | 72 | 2016 |
| DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel K Takamochi, F Takahashi, Y Suehara, E Sato, S Kohsaka, T Hayashi, ... Lung Cancer 110, 26-31, 2017 | 69 | 2017 |
